Risk factors of development of hepatocellular carcinoma
Abstract
The aim of review. To draw attention of general practitioners to the risk factors of hepatocellular carcinoma (HCC) development, to define group of patients with high probability of development of this tumor, to outline algorithm of screening diagnostics for patients of high risk group.
Original positions of the report. Independent risk factors for HCC development include hepatitis B and C viruses, the level of hepatitis B viral load, the stage of liver cirrhosis, male gender, age over 40 years, alcohol intake and smoking. Patients of high risk group should undergo investigation of alpha-fetoprotein level and abdominal US once per 6 months for early diagnostics of HCC; at detection of any liver lesions further deep investigation including computer and magnetic-resonance tomography, guided biopsy of the lesion is indicated.
Conclusion. According to present studies data, morbidity of HCC all over the world steadily grows. High risk group for HCC include patients of male gender over 50 years old (for Caucasian patients) with liver cirrhosis, especially of viral etiology, smoking and consuming alcohol. Prophylaxis of HCC should include prevention of hepatites B and C viruses infection, elimination of hepatotoxic substances, hepatitis B virus vaccination, antiviral therapy for patients with hepatites B and С. Patients from HCC risk groups need to be screened for tumor regularly (once in half a year). Its detection at the early stage allows to start medical actions in time, that helps to increase patients’ survival rate.
About the Authors
V. T. Ivashkin
Московская медицинская академия им. И.М. Сеченова
Russian Federation
Russian Federation
M. A. Morozova
Московская медицинская академия им. И.М. Сеченова
Russian Federation
Russian Federation
M. V. Mayevskaya
Московская медицинская академия им. И.М. Сеченова
Russian Federation
Russian Federation
I. A. Sokolina
Московская медицинская академия им. И.М. Сеченова
Russian Federation
Russian Federation
Ye. N. German
Московская медицинская академия им. И.М. Сеченова
Russian Federation
Russian Federation
M. V. Bundina
Московская медицинская академия им. И.М. Сеченова
Russian Federation
Russian Federation
References
1. Болезни печени и желчевыводяих путей: Руководство для врачей / Под ред. В.Т. Ивашкина. – М.: Изд. дом «М-Вести», 2002. – С. 405–410.
2. Ивашкин В.Т., Герман Е.Н., Маевская М.В. Скрытая инфекция вирусом гепатита В // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2008. – Т. 18, № 2. – С. 4.
3. Ивашкин В.Т., Павлов Ч.С. Опухоли печени, предраковые заболевания и состояния. Гепатоцеллюлярная карцинома // Рациональная фармакотерапия заболеваний органов пищеварения. – М.: Литтерра, 2003. – С. 459–464.
4. Майер К.П. Гепатит и последствия гепатита: Практич. руководство / Пер. с нем. – 2-е изд., перераб. и доп. – М.: ГЕОТАР-Медиа, 2004. – 720 с.
5. Павлов Ч.С., Галимова С.Ф., Ивашкин В.Т. и др. Динамика гистологической активности хронического гепатита В (ХВГ-В) у больных, леченных ламивудином // Материалы 11-й Рос. конф. «Гепатология сегодня» // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2006. – Т. 16, № 1. – С. 39.
6. Arguedas M.R., Chen V.K., Eloubeidi M.A., Fallon M.B. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis // Am. J. Gastroenterol. – 2003. – Vol. 98. – P. 679–690.
7. Bosch F.X., Ribes J., Diaz M., Cleries R. Primary liver cancer: worldwide incidence and trends // Gastroenterology. – 2004. – Vol. 127, N 5 (suppl. 1). – P. 5–16.
8. Bruix J., Sherman M., Llovet J.M. et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona–2000 EASL Conference // J. Hepatol. – 2001. – Vol. 35, N 3. – P. 421–430.
9. Caturelli E., Solmi L., Anti M. et al. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study // Gut. – 2004. – Vol. 53. – P. 1356–1362.
10. Chalasani N., Horlander J.C.Sr., Said A. et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis // Am. J. Gastroenterol. – 1999. – Vol. 94. – P. 2988–2993.
11. Denies L., Ernst O., Sergent-Baudson G. Contribution of spiral CT for the early diagnosis of hepatocellular carcinoma in cirrhotic patients // J. Radiol. – 2002. – Vol. 83, N 5. – P. 635–640.
12. El-Serag H.B. Hepatocellular carcinoma: recent trends in the United States // Gastroenterology. – 2004. – Vol. 127, N 5 (suppl. 1). – P. 27–34.
13. Everson G.T. Treatment of patients with hepatitis C virus on the waiting list // Liver Transplant. – 2003. – Vol. 9 (suppl. 3). – P. 90–94.
14. Everson G.T., Trotter J.F., Kugelmas M. Long term outcome of patients with chronic hepatitis C and decompensated liver disease treated with the LADR protocol (low accelerating dose regimen) // Hepatology. – 2002. – Vol. 36. – Abstract.
15. Federle M.P. Use of radiologic techniques to screen for hepatocellular carcinoma // J. Clin. Gastroenterol. – 2002. – Vol. 35. – P. 92–100.
16. Hashem B., El-Serag H.B. Epidemiology of hepatitis C-related hepatocellular carcinoma. medscape // Medscape Gastroenterology. – 2007. – http://www.medscape.com/viewarticle/560012
17. Koike K., Tsutsumi T., Fujie H. et al. Molecular mechanism of viral hepatocarcinogenesis // Oncology. – 2002. – Vol. 62 (suppl. 1). – P. 29–37.38.
18. Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma:an Eastern point of view // Liver Transplant. – 2004. – Vol. 10, N 2 (suppl. 1). – P. 3–8.158.
19. Levy I., Greig P.D., Gallinger S. et al. Resection of hepatocellular carcinoma without preoperative tumor biopsy // Ann. Surg. – 2001. – Vol. 234. – P. 206–209.
20. Liaw Y.F., Sung J.J., Chow W.C. et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease // N. Engl. J. Med. – 2004. – Vol. 351. – P. 1521–1531.
21. Lim J.H., Kim C.K., Chiang L.W. et al. CT detection of hepatocellular carcinoma in advanced liver cirrhosis: correlation with helical CT and explanted liver // Taehan Kan Hakhoe Chi. – 2002. – Vol. 8. – P. 201–208.
22. Lim J.H., Kim C.K., Lee W.J. et al. Detection of hepatocellular carcinomas and dysplastic nodules in cirrotic livers: accuracy of helical CT in transplant patients // AJR. Am. J. Roentgenol. – 2000. – Vol. 175. – P. 693–698.
23. Miller W.J., Federle M.P., Campbell W.L. Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 36 liver transplantation patients // AJR. Am. J. Roentgenol. – 1991. – Vol. 157. – P. 303–306.
24. Mortele K.J., de Keukeleire K., Praet M. Malignant focal hepatic lesions complicating underlying liver disease: dual-phase contrast-enhanced spiral CT sensitivity and specificity in orthotopic liver transplant patients // Eur. Radiol. – 2001. – Vol. 11, N 9. – P. 1631–1638.
25. Nakashima Y., Nakashima O., Tanaka M. et al. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type // Hepatol. Res. – 2003. – Vol. 26. – P. 142–147.
26. Okuda K., Ohtsuki T., Obata H. et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment // Cancer. – 1985. – Vol. 56. – P. 918–928.
27. Peterson M.S., Baron R.L., March J.W. et al. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation // Radiology. – 2000. – Vol. 217. – P. 743–749.
28. Pineda J.A., Romero-Gomez M., Diaz-Garcia F. et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis // Hepatology. – 2005. – Vol. 41. – P. 779–789.
29. Puoti M., Bruno R., Soriano V. et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome // AIDS. – 2004. – Vol. 18. – P. 2285–2293.
30. Rode A., Bancel B., Douek P. et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver // J. Comput. Assist. Tomogr. – 2001. – Vol. 25. – P. 327–336.
31. Rosenthal E., Poiree M., Pradier C. et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study) // AIDS. – 2003. – Vol. 17. – P. 1803–1809.
32. Sakamoto M., Hirohashi S. Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection // Jpn. J. Clin. Oncol. – 1998. – Vol. 28. – P. 604–608.
33. Sakuma K., Saitoh N., Kasai M. et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study // Hepatology. – 1988. – Vol. 8. – P. 1642–1646.
34. Stevens W.R., Johnson C.D., Stephens D.H. et al. CT findings in hepatocellular carcinoma: correlation of tumor characteristics with causative factors, tumor size, and histologic tumor grade // Radiology. – 1994. – Vol. 191. – P. 531–537.
35. Tanaka Y., Mukaide M., Orito E. et al. Specific mutations ib enhancer II/core promoter of hepatitis B virus subgenotipes C1/C2 increase the risk of hepatocellular carcinoma // Hepatology. – 2006. – Vol. 45. – P. 645–653.
36. The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients // Hepatology. – 1998. – Vol. 28. – P. 751–755.
37. Nands J. Hepatocellular carcinoma and sex. N. Eng. J. Med. – 1974. Vol. 357, november 8, 2007
Review
For citations:
Ivashkin V.T., Morozova M.A., Mayevskaya M.V., Sokolina I.A., German Ye.N., Bundina M.V. Risk factors of development of hepatocellular carcinoma. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2009;19(1):4-15. (In Russ.)
Views:
99
Email this article 
